These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 31971278

  • 1. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
    Rabban JT, Devine WP, Sangoi AR, Poder L, Alvarez E, Davis JL, Rudzinski E, Garg K, Bean GR.
    Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
    [Abstract] [Full Text] [Related]

  • 2. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR.
    Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
    [Abstract] [Full Text] [Related]

  • 3. NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion.
    Szalai L, Vereczkey I, Szemes M, Rókusz A, Csernák E, Tóth E, Melegh Z.
    Virchows Arch; 2024 Mar; 484(3):527-531. PubMed ID: 38151535
    [Abstract] [Full Text] [Related]

  • 4. NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Costigan DC, Nucci MR, Dickson BC, Chang MC, Song S, Sholl LM, Hornick JL, Fletcher CDM, Kolin DL.
    Am J Surg Pathol; 2022 Oct 01; 46(10):1415-1429. PubMed ID: 35713627
    [Abstract] [Full Text] [Related]

  • 5. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb 01; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 6. S100 and Pan-Trk Staining to Report NTRK Fusion-Positive Uterine Sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
    Chiang S.
    Int J Gynecol Pathol; 2021 Jan 01; 40(1):24-27. PubMed ID: 33290352
    [Abstract] [Full Text] [Related]

  • 7. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
    Tsai JW, Lee JC, Hsieh TH, Huang SC, Lee PH, Liu TT, Kao YC, Chang CD, Weng TF, Li CF, Lin JC, Liang CW, Su YL, Chang IY, Wang YT, Chang NY, Yu SC, Wang JC, Huang HY.
    Mod Pathol; 2022 Jul 01; 35(7):911-921. PubMed ID: 35149769
    [Abstract] [Full Text] [Related]

  • 8. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
    Zhao R, Yao F, Xiang C, Zhao J, Shang Z, Guo L, Ding W, Ma S, Yu A, Shao J, Zhu L, Han Y.
    J Pathol Clin Res; 2021 Jul 01; 7(4):375-384. PubMed ID: 33768710
    [Abstract] [Full Text] [Related]

  • 9. NTRK-rearranged Cervical Sarcoma: Expanding the Clinicopathologic Spectrum.
    Hodgson A, Pun C, Djordjevic B, Turashvili G.
    Int J Gynecol Pathol; 2021 Jan 01; 40(1):73-77. PubMed ID: 32044823
    [Abstract] [Full Text] [Related]

  • 10. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
    Moura MS, Costa J, Velasco V, Kommoss F, Oliva E, Le Loarer F, McCluggage WG, Razack R, Treilleux I, Mills A, Longacre T, Devouassoux-Shisheboran M, Hostein I, Azmani R, Blanchard L, Hartog C, Soubeyran I, Khalifa E, Croce S.
    Histopathology; 2024 Feb 01; 84(3):451-462. PubMed ID: 37988282
    [Abstract] [Full Text] [Related]

  • 11. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov 01; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 12. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B.
    Mod Pathol; 2021 Feb 01; 34(2):396-407. PubMed ID: 32860002
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J, Park JW, Won JK, Bae JM, Koh J, Yim J, Yun H, Kim SK, Choi JY, Kang HJ, Kim WS, Shin JH, Park SH.
    Diagn Pathol; 2020 Sep 21; 15(1):114. PubMed ID: 32957984
    [Abstract] [Full Text] [Related]

  • 14. Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms.
    Croce S, Hostein I, Longacre TA, Mills AM, Pérot G, Devouassoux-Shisheboran M, Velasco V, Floquet A, Guyon F, Chakiba C, Querleu D, Khalifa E, Mayeur L, Rebier F, Leguellec S, Soubeyran I, McCluggage WG.
    Mod Pathol; 2019 Jul 21; 32(7):1008-1022. PubMed ID: 30877273
    [Abstract] [Full Text] [Related]

  • 15. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
    Zhang W, Schmitz AA, Kallionpää RE, Perälä M, Pitkänen N, Tukiainen M, Alanne E, Jöhrens K, Schulze-Rath R, Farahmand B, Zong J.
    Acta Oncol; 2024 Jul 05; 63():542-551. PubMed ID: 38967220
    [Abstract] [Full Text] [Related]

  • 16. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL.
    Am J Surg Pathol; 2018 Jul 05; 42(7):927-935. PubMed ID: 29683818
    [Abstract] [Full Text] [Related]

  • 17. NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China.
    Yin L, Shi C, He X, Qiu Y, Chen H, Chen M, Zhang Z, Chen Y, Zhou Y, Zhang H.
    Pathology; 2023 Apr 05; 55(3):362-374. PubMed ID: 36641377
    [Abstract] [Full Text] [Related]

  • 18. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
    Endocr Pathol; 2020 Dec 05; 31(4):348-358. PubMed ID: 32880785
    [Abstract] [Full Text] [Related]

  • 19. Uterine Neurotrophic Tyrosine Receptor Kinase Rearranged Spindle Cell Neoplasms: Three Cases of an Emerging Entity.
    Grant L, Boyle W, Williams S, Pascoe J, Ganesan R.
    Int J Gynecol Pathol; 2024 Jul 01; 43(4):326-334. PubMed ID: 37922944
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan.
    Nakata E, Osone T, Ogawa T, Taguchi T, Hattori K, Kohsaka S.
    Cancer Med; 2024 Jun 01; 13(12):e7351. PubMed ID: 38925616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.